Pacific Edge slashes team on US 'uncertainty'

Pacific Edge slashes team on US 'uncertainty'
(Image: PEB)
Brent Melville
Pacific Edge has halved its sales team after uncertainty over its future in its core US market, with a pending decision on whether medicare contractor Novitas will cover US testing.  The cancer diagnostic company, dual listed on the New Zealand and Australian stock exchanges, slashed its commercial team from 34 to 17 as it restructured its operations after a 17.78% drop in test volumes for its Cxbladder product in its core US market for the December quarter.The Dunedin firm said it had processed 7,172 tests during the final three months of...

More Markets

Asset recycling: privatisation or better housekeeping
Policy

Asset recycling: privatisation or better housekeeping

On asset recycling, Silvana Schenone cites Marie Kondo rather than Milton Friedman.

Early Sharesies investors take $20m payday
Markets

Early Sharesies investors take $20m payday

Just under 3% of the company's shares changed hands.

NZ stocks end lower while Eroad tanks
Markets Market Close

NZ stocks end lower while Eroad tanks

The S&P/NZX 50 Index dropped 99.89 points or 0.75% to 13,289.21.

Jamie Gray 17 Oct 2025
Macpac NZ profits drop 71% as softer sales hit margins
Retail

Macpac NZ profits drop 71% as softer sales hit margins

The sales drop in New Zealand was larger than Kathmandu's.

Gregor Thompson 17 Oct 2025